Haleon (NYSE:HLN) Stock Rating Raised to Hold at Deutsche Bank Aktiengesellschaft

Posted by Brian Himes on Oct 31st, 2026

Deutsche Bank Aktiengesellschaft upgraded shares of Haleon (NYSE:HLN – Free Report) from a sell rating to a hold rating in a research note published on Friday, Marketbeat.com reports.

Several other brokerages also recently weighed in on HLN. Wall Street Zen downgraded shares of Haleon from a “buy” rating to a “hold” rating in a research report on Saturday, October 3rd. Zacks Research cut Haleon from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 22nd. Berenberg Bank reiterated a “buy” rating on shares of Haleon in a research note on Wednesday, August 5th. Jefferies Financial Group restated a “buy” rating on shares of Haleon in a research note on Wednesday, September 23rd. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a report on Friday, September 25th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $4.90.

Read Our Latest Research Report on Haleon

Haleon Stock Up 1.1%

NYSE:HLN opened at $8.66 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.52 and a current ratio of 0.69. The firm has a market cap of $38.14 billion, a P/E ratio of 22.21, a P/E/G ratio of 1.93 and a beta of 0.14. Haleon has a fifty-two week low of $8.38 and a fifty-two week high of $11.28. The firm has a 50-day simple moving average of $9.54 and a two-hundred day simple moving average of $9.77.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Public Employees Retirement System of Ohio lifted its position in shares of Haleon by 136.4% during the 1st quarter. Public Employees Retirement System of Ohio now owns 222,708 shares of the company’s stock valued at $2,229,000 after buying an additional 128,493 shares in the last quarter. Bank of America Corp DE grew its stake in shares of Haleon by 17.0% during the 1st quarter. Bank of America Corp DE now owns 10,934,228 shares of the company’s stock valued at $109,452,000 after acquiring an additional 1,586,230 shares during the period. Squarepoint Ops LLC purchased a new stake in Haleon in the 2nd quarter worth approximately $1,186,000. Engineers Gate Manager LP purchased a new stake in Haleon in the 2nd quarter worth approximately $1,869,000. Finally, Goodman Financial Corp purchased a new stake in Haleon in the 1st quarter worth approximately $11,488,000. Hedge funds and other institutional investors own 6.67% of the company’s stock.

More Haleon News

Here are the key news stories impacting Haleon this week:

Positive Sentiment: Deutsche Bank upgraded Haleon from “sell” to “hold,” removing a bearish recommendation and potentially helping stabilize the stock after its recent decline. Deutsche Bank Haleon recommendations
Positive Sentiment: Haleon announced a £500 million share buyback, which could support earnings per share and signal that management views the current valuation as attractive. Haleon cuts 2026 forecast and announces buyback
Neutral Sentiment: Analysts continue to compare Haleon with other consumer-products companies on valuation. The discussion may attract value-focused investors, but it does not provide a major new company-specific catalyst. ASAIY or HLN value stock comparison
Negative Sentiment: Haleon cut its 2026 organic revenue growth forecast to 2.5% after reporting weaker-than-expected sales. The downgrade raises concerns about slowing demand, pricing pressure and reduced near-term earnings momentum. Haleon cuts 2026 organic revenue forecast
Negative Sentiment: Chief Executive Brian McNamara warned employees that “difficult choices” may be required following the sales miss, increasing the risk of cost reductions or restructuring. Haleon CEO warns of difficult choices
Negative Sentiment: Commentary characterized Haleon’s sales performance as a weakness requiring tougher corrective action, reinforcing investor concerns about the company’s growth trajectory. Haleon sales commentary

Haleon Company Profile

(Get Free Report)

Haleon plc (NYSE: HLN) is a global consumer health company that develops, manufactures and markets over-the-counter medicines, oral health products, vitamins and supplements. Its portfolio is organized around categories including pain relief, respiratory health, digestive health, therapeutic oral care, everyday oral care, vitamins and minerals, and skin health.

Haleon’s well-known brands include Sensodyne, Polident, parodontax, Centrum, Advil, Voltaren, Panadol, Otrivin and Theraflu. The company’s products are sold through pharmacies, supermarkets, retailers and e-commerce channels, serving consumers in markets around the world.

Haleon was established as an independent consumer health business following its demerger from GSK in July 2022.